SCIENCE. TECHNOLOGY. BUSINESS.

FOR PHARMA, PATIENTS, PAYERS AND PROVIDERS

SPONSOR NOW

INDUSTRY EXPERTS CONFIRMED TO SPEAK INCLUDE

Nicholas Dracopoli
VP, Head of Oncology Biomarkers

Matt Nelson
Head of Genetics

Peter Shaw
Head of Clinical Pharmacogenetics

VIEW ALL

CONFERENCE

With a variety of interactive sessions, this event is designed to tackle Next-Generation Therapeutics, Tomorrow’s Clinical Trials, Commercializing Precision Medicine, Precision Medicine Ex-Oncology .

READ MORE

SPONSOR

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

READ MORE

NETWORK

We offer a variety of networking opportunities from Speed Networking to 1-2-1 Partnering sessions ro ensure that you meet as many other attendees as possible in 2 days.

READ MORE

DOWNLOAD THE PROSPECTUS

The prospectus for this year's event is now available! Learn more about the largest precision medicine event focusing on commercial, actionable goals!

DOWNLOAD PROSPECTUS

2017 Sponsors & Exhibitors

Bronze Sponsor
Event Sponsor
Exhibitor

DOWNLOAD PROSPECTUS

CONFIRMED SPEAKERS

Abdel Halim
Vice President Translational Medicine, Biomarkers and Diagnostics
Celldex Therapeutics

Lyndsay Harris
Deputy Associate Director - Cancer Diagnosis Program
National Cancer Institute
Edmund Pezalla
Former VP Pharmaceutical Policy and Strategy
Aetna

Kurt Schalper
Director, Translational Immuno Oncology Laboratory
Yale Cancer Center
David Smith
Professor of Laboratory Medicine And Pathology
Mayo Clinic

James Smothers
Vice President, DPU Head Immuno-Oncology & Combinations DPU RD Oncology R&D
GlaxoSmithKline Plc
Keith Tanis
Principal Scientist - Genetics, Genomics & Bioinformatics
Merck and Co Inc

Dr Alexa T. McCray
Director, Center for Biomedical Informatics
Harvard Medical School
Kenna Mills Shaw
Exec. Dir, Institute For Personalized Cancer Therapy
M.D. Anderson Cancer Center

Romina Ortiz
VP Policy & Patient Advocacy
Rare Genomics Institute
Steven Swanson
Senior Vice President, Research
Immunocellular Therapeutics

Jessilyn Pearl Dunn
Postdoctoral Research Fellow, Genetics
Stanford University School of Medicine
Randy Burkholder
VP Policy & Research
Pharmaceutical Research and Manufacturers of America (PhRMA)

Arnold Gelb
Global Head of Companion Diagnostic Development and Site Head U.S.
E.M.D. Serono Inc
Stephen Groft
Senior Advisor to the Director, NCATS
N.I.H

Ruslan Novosiadly
Senior Research Advisor Cancer Immunobiology Biomarkers
Eli Lilly and Co
Ronald Przygodzki
Director, Genomic Medicine Implementation
U.S. Department of Veterans Affairs

Nazneen Aziz
Executive Director
Kaiser Permanente Research Bank
Ying Chen
Senior Bioinformatics Specialist
Rutgers Cancer Institute of New Jersey

Eric Michael David
Chief Strategy Officer and Executive Vice President of Preclinical Development
Organovo
Jennifer Hall
Chief, Institute for Precision Cardiovascular Medicine
American Heart Association

James O'Leary
Chief Innovation Officer
Genetic Alliance
Peter White
Director, Division of Biomedical Informatics
Cincinnati Children's Hospital Medical Center

Ann Wu
Director, Precision Medicine Translational Research Center
Harvard Pilgrim Health Care
Rong Chen
Director - Institute of Genomics
The Mount Sinai Hospital

Scott Kahn
Former CIO and VP Informatics
Illumina
Linda Bulone
Research Nurse Manager
Queens Hospital Cancer Center

Rodolphe Clerval
Chief Business Officer and Vice President of U.S. Operations
Enterome Bioscience
Micah MacKison
Vice President of Corporation Development and Strategy
Assembly Biosciences, Inc.

Henry Rath
Vice President of Business Development
Seres Therapeutics Inc
Nikola Trbovic
Sr Dir, Head R&D Technology Strategy
Pfizer

Peter Shaw
Head of Clinical Pharmacogenetics
Merck
Scott Josephs
VP & National Medical Officer
Cigna Healthcare

Jean-Claude Marshall
Head of Clinical Genetics and Biospecimens
Pfizer
Ralph Riley
Leader of Health Economics and Pricing for Companion Diagnostics
Janssen Diagnostics Llc

Dr Ena Bromley
President and Chief Scientific Officer
BioStat Solutions Inc
Eric Kmiec
Director of Gene Editing Institute
Christiana Care Health System

Rebecca Blanchard
Head of Clinical Pharmacogenomics, Executive Director
MSD
C. Karen Jeans
Associate Director, Regulatory Affairs
U.S. Department of Veterans Affairs

Danit Oz Levi
Sequencing Analysis & Bioinformatics Expert
Teva Pharmaceuticals
Charles Paulding
Director Pharmacogenomics
Regeneron Pharmaceuticals

Michelle Penny
Senior Director, Head of Computational Biology and Genomics
Biogen
Gil Alterovitz
Director, Biomedical Cybernetics Laboratory Computational Health Informatics Program
Harvard Medical School Department of Biomedical Informatics

Iris Grossman
Vice President, Head of Personalized & Predictive Medicine, Analytics and Big Data
Teva Pharmaceutical Industries
Meg Ehm
Director of Genetics
GSK

Dr Marcie Glicksman
CSO
ORIG3N
Mark Jensen
Director/Genomic Data Programs
Frederick National Laboratory for Cancer Research

Pashtoon Kasi
Assistant Professor, Gastrointestinal Malignancies
Mayo Clinic
Bat-ami Katzman Gordon
Project manager of Precision Medicine at the Sylvester Comprehensive Cancer Center
University of Miami

Chris Major
Director Diagnostic Development
Janssen
Mark Punyanitya
President &CEO
PhenoMx

Mehrdad Yazdani
Data Scientist
Open Medicine Institute